Last updated on November 2018

Tepotinib Phase II in Non-small Cell Lung Cancer (NSCLC) Harboring MET Alterations

Brief description of study

This study will look at how effective the study drug (tepotinib) is at stopping the growth and spread of lung cancer. This study will also measure a number of other things including safety of the study drug and the side effects, how body processes the study drug, or how the study drug affects your quality of life. The study also has an optional pharmacogenetic research part. Pharmacogenetic research is an important way to try to understand the role of genetics in human disease and how genes impact the effectiveness of drugs, because differences in genes can change the way a person responds to a particular drug.

Clinical Study Identifier: NCT02864992

Find a site near you

Start Over

Torrance Health Association

Redondo Beach, CA United States
  Connect »

AZ Delta

Roeselare, Belgium
  Connect »

Holy Cross Hospital Inc.

Fort Lauderdale, FL United States
  Connect »

UCI Medical Center

Orange, CA United States
  Connect »

Winship Cancer Institute

Atlanta, GA United States
  Connect »

Ingalls Hospital

Harvey, IL United States
  Connect »

Community Regional Cancer Care

Indianapolis, IN United States
  Connect »

St. Louis Cancer Care, LLP

Bridgeton, MO United States
  Connect »

Saint Louis University

Saint Louis, MO United States
  Connect »

Tennessee Oncology

Nashville, TN United States
  Connect »

Texas Oncology, PA

Beaumont, TX United States
  Connect »

Texas Oncology, P.A.

Dallas, TX United States
  Connect »

Swedish Medical Center

Seattle, WA United States
  Connect »

UZ Antwerpen

Edegem, Belgium
  Connect »

ICO - Site Paul Papin

Angers Cedex 2, France
  Connect »

H pital Saint-Louis

Paris Cedex 10, France
  Connect »

Saitama Cancer Center

Kitaadachi-gun, Japan
  Connect »

Hospital General de Catalunya

Sant Cugat del Valles, Spain
  Connect »

Hospital Universitario Infanta Sofia

San Sebastian de los Reyes, Spain
  Connect »

The Valley Hospital

Ridgewood, NJ United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.